Companies: 10,795·Total market cap: $144.5T
INNOCAN PHARMA Corp

INNOCAN PHARMA Corp

INNPFOTCHealthcare● Active
$2.40
$-0.05(-2.04%)
Market Cap$10797048
P/E Ratio
52W High$14.26
52W Low$2.354
Overview

INNOCAN PHARMA Corp (INNPF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · INNPF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.33innpf eps ttm · innpf earnings per shareEarnings history
PE Ratio (TTM)innpf pe ratio ttm · innpf price to earningsPE Ratio deep dive
Revenue (TTM)$25.2Minnpf revenue ttm · innpf annual revenueFull revenue history
Dividend YieldNo Dividenddoes innpf pay dividends · innpf dividend yieldDividend history
Shares Outstanding4.5Minnpf shares outstanding · innpf floatShares outstanding history
Next EarningsTBAinnpf earnings date · innpf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$26.6M▼ 9.60% YoY
202320242025
innocan pharma corp revenue · innpf revenue 2025
FY 2025Net Income-$1.1M▲ +38.71% YoY
202320242025
innocan pharma corp net income · innpf profit 2025
FY 2025EPS$-0.25▲ +40.48% YoY
202320242025
innpf eps · innocan pharma corp earnings per share 2025
TTM:Revenue: $25.2MNet Income: -$1.5MEPS: $-0.33View income statement →

Stock Performance

Full History
1D-2.04%
1W-2.04%
1M-45.45%
3M-56.04%
YTD-66.80%
1Y-67.61%
5Y-90.87%

About INNOCAN PHARMA Corp

CEOIris Bincovich
IPO DateNov 27, 2020
Employees11
CountryCA

INNOCAN PHARMA Corp oration is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend …

what is innocan pharma corp · innpf stock overview · innocan pharma corp company profile · who is innocan pharma corp ceo · innpf OTC · innocan pharma corp headquarters · innocan pharma corp business segments

About Stock Overview & Key Data

INNOCAN PHARMA Corp (INNPF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Nov 27, 2020. As of the latest trading session, INNPF stock price is $2.40, with a market capitalization of $10.8M. The stock has returned -67.61% over the past 12 months and -66.80% year-to-date.

In fiscal year 2025, INNOCAN PHARMA Corp reported revenue of $26.6M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, INNOCAN PHARMA Corp (INNPF) stock price is $2.40. The stock is traded on OTC under the ticker symbol INNPF. The 52-week range is $2.35 – $14.26.

INNPF stock priceINNPF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice